Kalorama: Global Blood Testing, Collection and Products Market Growing
NEW YORK, Oct. 28, 2014 /PRNewswire/ -- The global blood industry has experienced strong growth in recent years and growth will remain solid though 2018, according to Kalorama Information. The market for human blood and blood components continues to expand as a result of the growing and aging populations in the U.S., Europe and Japan, ongoing technology advancements/new product introductions and indications, expansion of health coverage in the U.S. via healthcare reform and continued strong promotion of blood donation by collection agencies.
The U.S. is the single largest global market for blood products such as plasma. "The expanded health coverage the Affordable Care Act brings in the U.S. will help to drive the global market," the report stated.
The report, Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products can be found at http://www.kaloramainformation.com/redirect.asp?progid=86796&productid=8437179.
While some countries such as India and the Philippines set prices for blood and blood components, in many of the developed nations, including the U.S., there is no uniform, fixed price for blood. Rather, the cost varies from country to country and region to region, with even nearby centers often charging different prices and fluctuations often occurring.
The global blood market consists of more than blood collection. It includes blood typing and testing for diseases, blood storage and processing, blood transfusions, blood management and safety issues, synthetic blood products, the blood products market, the blood testing and typing products market, the plasma and blood collection equipment market and the synthetic blood products market. The blood products market is a good example of the larger market in microcosm. In 2012, worldwide demand for non-infected blood exceeded 200 million pints. Of this, red blood cells (RBCs) comprised 105 million units. Through 2018, global demand for RBCs is expected to reach 140 million units.
The healthcare market researcher's report provides an analysis of all the key blood market segments involved in this industry, including products, equipment and testing. In addition to complete market data, including forecasts to 2018, the study reports product demand estimates by region, collection and transfusion estimates, high-blood-loss procedure estimates, product pricing, reimbursement rates and products on the market and in development.
The effective management of blood supplies is a critical issue for the blood industry, which continues to be challenged with a growth in demand that exceeds any increases in supply. The U.S. may be the single largest consumer, but demand is high and continues to grow in other developed countries such as China, Japan, and Germany as well.
Blood: The Worldwide Market provides discussions of key trends, as well as the regulatory, business, and clinical challenges facing the various sectors of the blood industry. The report also profiles key companies in the industry, including:
- AABB
- Abbott Laboratories
- Akers Biosciences
- America's Blood Centers
- American Red Cross
- Baxter International
- Bayer AG
- BD
- BDI Pharma
- Beckman Coulter
- Beijing Tiantan Biological Products, Ltd.
- Bharat Serums and Vaccines Ltd.
- Bio-Rad Laboratories
- Biotest Pharmaceuticals
- BioTime Inc.
- CHINA BIOLOGIC
- CSL BEHRING
- DiaSorin
- Emergent Biosolutions
- Ethicon Biosurgery
- Fenwal/Fresenius Kabi
- Gen-Probe Inc./Hologic
- Grifols Biologicals, Inc.
- HAEMONETICS, INC.
- HUALAN BIOLOGICAL ENGINEERING
- IMMUCOR
- Kamada
- Lanzhou Institute of Biological Products Nordisk
- LFB
- Micronics
- Novo Nordisk A/S
- Octapharma AG
- OPK BioTech
- ORTHO CLINICAL DIAGNOSTICS
- Oxygen Biotherapeutics
- Pfizer
- ProMetic Biosciences
- Reliance Life Sciences
- Roche
- Ronsen Pharma
- Shanghai RAAS Blood Products Co., Ltd.
- Shire plc
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- Sinosource Biopharmaceutical, Inc.
- Takeda
- Terumo BCT
- Walvax Biotechnology Co., Ltd.
Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2008 to 2013 period and forecasts are provided through 2018. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis. The report can be found at KI: http://www.kaloramainformation.com/redirect.asp?progid=86796&productid=8437179.
About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-global-blood-testing-collection-and-products-growing-643791042.html
SOURCE Kalorama Information
Share this article